Israeli midfielder Anan Khalaili’s highly anticipated move to Inter Milan has been called off after he failed his medical examination, a development that underscores the growing scrutiny surrounding high‑value transfers in European football.
Medical Examination Halts High‑Profile Transfer
The €30 million transfer, which would have set a new record for an Israeli player, was officially scrapped by the Serie A club on Tuesday. Inter Milan’s president, Giuseppe Marotta, confirmed the decision during a press conference, emphasizing that the player’s health could not meet the stringent medical standards imposed by Italian regulations.
Marotta explained that the club’s medical team identified concerns that could not be resolved within the timeframe required by the league’s health protection statutes. “Our priority is the well‑being of the athlete and compliance with the law,” he stated, adding that the decision was made to avoid any risk of future complications.
The cancellation marks the second time in recent weeks that a promising Israeli talent has seen a marquee move dissolve over medical hurdles. Earlier, players such as Oscar Gloukh, Munas Dabbur and Manor Solomon had attracted comparable interest, but their transfers also stalled for similar reasons.
While the financial implications of the aborted deal are significant, the episode also raises broader questions about the pathways for Israeli athletes seeking to compete at the highest levels of European sport. The role of governing bodies like CONI in monitoring health compliance may become a focal point of future negotiations.
For now, Khalaili’s future remains uncertain, but the midfielder is expected to continue his development in the Israeli Premier League while clubs abroad reassess the feasibility of high‑cost signings under the current medical framework.